In hematologic malignancy, leukemia cell survival and chemotherapeutic drug resistance were promoted by the binding of Nrf2 to antioxidant response elements (AREs) located in the 5′ untranslated regions of miR-125B and miR-29B [41]. The gene discussed is NFE2L2; the disease is leukemia.